Texwinca Holdings Limited (HKG:0321)
0.8700
-0.0100 (-1.14%)
Jul 31, 2025, 4:08 PM HKT
Oncternal Therapeutics Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 116.07 | 132.33 | 75.15 | 191.06 | 274.21 | Upgrade |
Depreciation & Amortization | 402.44 | 375.93 | 381.44 | 464.91 | 463.63 | Upgrade |
Loss (Gain) From Sale of Assets | -2.75 | -10.52 | -3.7 | 6.12 | 2.56 | Upgrade |
Asset Writedown & Restructuring Costs | 38.14 | 13.19 | -4.78 | 26.69 | 13.75 | Upgrade |
Loss (Gain) From Sale of Investments | -0.71 | 1.33 | -11.62 | 4.59 | -7.98 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | -28.8 | -8.84 | Upgrade |
Provision & Write-off of Bad Debts | -2.17 | -6.9 | -2.64 | -22.13 | 18.08 | Upgrade |
Other Operating Activities | -188.36 | 10.29 | -232.05 | 431.84 | 99.31 | Upgrade |
Change in Accounts Receivable | -15.09 | -142.26 | 279.88 | 79.78 | -224.08 | Upgrade |
Change in Inventory | 316.09 | -60.9 | 881 | -168.57 | -112.27 | Upgrade |
Change in Accounts Payable | -66.92 | 137.83 | -431.07 | 28.38 | 133.85 | Upgrade |
Change in Other Net Operating Assets | -87.77 | -61.57 | 92.11 | -111.3 | 50.16 | Upgrade |
Operating Cash Flow | 508.97 | 388.74 | 1,024 | 902.59 | 702.38 | Upgrade |
Operating Cash Flow Growth | 30.93% | -62.03% | 13.42% | 28.50% | 6.02% | Upgrade |
Capital Expenditures | -295.28 | -215.66 | -250.14 | -291.74 | -188.16 | Upgrade |
Sale of Property, Plant & Equipment | 86.06 | 15.49 | 16.18 | 19.4 | 2.38 | Upgrade |
Cash Acquisitions | - | -596.18 | - | - | - | Upgrade |
Divestitures | - | - | - | 2.67 | - | Upgrade |
Investment in Securities | 726.26 | -338.16 | 1,119 | -1,303 | 682.38 | Upgrade |
Other Investing Activities | 86.17 | 94.05 | 39.9 | 66.93 | 78.63 | Upgrade |
Investing Cash Flow | 603.22 | -1,040 | 924.83 | -1,506 | 575.23 | Upgrade |
Long-Term Debt Issued | 3,529 | 2,472 | 2,437 | 3,830 | 1,875 | Upgrade |
Long-Term Debt Repaid | -3,704 | -2,238 | -3,464 | -3,615 | -2,470 | Upgrade |
Net Debt Issued (Repaid) | -175.65 | 234.76 | -1,027 | 215.16 | -594.66 | Upgrade |
Common Dividends Paid | -82.9 | -207.26 | -276.34 | -248.71 | -69.09 | Upgrade |
Other Financing Activities | -78.06 | -51.2 | -34.33 | -34.35 | -30.39 | Upgrade |
Financing Cash Flow | -336.61 | -23.69 | -1,338 | -67.89 | -694.14 | Upgrade |
Foreign Exchange Rate Adjustments | -2.12 | -51.63 | -21.3 | 18.16 | -23.76 | Upgrade |
Net Cash Flow | 773.45 | -727.04 | 589.53 | -653.3 | 559.71 | Upgrade |
Free Cash Flow | 213.69 | 173.08 | 773.58 | 610.84 | 514.22 | Upgrade |
Free Cash Flow Growth | 23.46% | -77.63% | 26.64% | 18.79% | -0.82% | Upgrade |
Free Cash Flow Margin | 3.83% | 3.23% | 12.77% | 7.60% | 7.00% | Upgrade |
Free Cash Flow Per Share | 0.15 | 0.13 | 0.56 | 0.44 | 0.37 | Upgrade |
Cash Interest Paid | 78.06 | 51.2 | 34.33 | 34.35 | 30.39 | Upgrade |
Cash Income Tax Paid | 48.63 | -37.6 | 86.7 | -306.15 | 32.66 | Upgrade |
Levered Free Cash Flow | 38.49 | 83.51 | 717.27 | 546.31 | 229.5 | Upgrade |
Unlevered Free Cash Flow | 87.28 | 115.51 | 738.72 | 567.78 | 248.49 | Upgrade |
Change in Net Working Capital | -15.93 | 49.54 | -735.09 | -230.76 | 210.28 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.